We investigated the effect of resveratrol on proliferation and induction of apoptosis of INS-1E rat insulinoma cells by cell counting, crystal violet staining, flow cytometry and immunoblotting. Resveratrol treatment of INS-1E cells at concentrations ≥ 50 µM resulted in a dose-dependent inhibition of cell proliferation, accumulation of the cells in the S and G0/G1 phase and a significant increase of the percentage of apoptotic cells. This was paralleled by an increase of cell granularity, apoptotic volume decrease (AVD), exposure of phosphatidylserine at the outer leaflet of the plasma membrane, an increase of the 7-AAD signal and caspase activation. The AMP-kinase (AMPK) inhibitor compound C (10 µM) significantly inhibited cell proliferation and induced caspase activation within 48 hours but this effect was not modified by resveratrol suggesting that AMPK is not a major target involved in mediating the proapoptotic effect of resveratrol in INS-1E cells. Immunoblotting revealed a significant inhibition of Akt (PKB) phosphorylation by 100 µM resveratrol within 1 hour. Addition of insulin (10 µM) to the culture medium strongly enhanced basal Akt phosphorylation. This enhancement was significantly attenuated by 50 and 100 µM resveratrol. We conclude that the antiproliferative/proapoptotic effect of resveratrol on INS-1E cells is due to negative interference with Akt signaling and most likely disruption of auto/paracrine insulin signaling.
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Introduction
The phytoalexin trans-resveratrol, which is synthesised by plant tissues in response to fungal infections or exposure to UV light [1] , has been shown to prevent or attenuate the progression of metabolic disorders, cardiovascular diseases or ischemic injuries and can enhance stress resistance. The drug is known for its antioxidant activity, can prevent platelet aggregation and tumor angiogenesis and has been shown to induce cell cycle arrest and apoptosis in primary tumor cells and several tumor cell lines [2] [3] [4] . The substance interferes with distinct cellular targets including cyclooxygenases, protein 246 kinase C, ornithindecarboxylase and sirtuin deacetylases (Sir2/SIRT1). Sir2/SIRT1 activation has been intensively investigated since it seems to underlie the potency of resveratrol to extend the lifespan in lower organisms [4] . The antiproliferative effect of resveratrol is due to interference with signaling cascades regulating cell proliferation/apoptosis like Akt (PKB)-and AMP-activated protein kinase (AMPK) signaling [5] [6] [7] [8] . In cultured muscle cells a downregulation of insulin-like pathways by resveratrol was found due to inhibition of phosphoinositide 3-kinase (PI3K) [9] .
It has been described in streptozotocin-nicotinamideinduced diabetic rats that resveratrol diminishes renal dysfunction and oxidative stress [10] , decreases hyperglycemia and hyperlipidaemia, enhances the tissue responsiveness to insulin and to delay the development of insulin resistance [11, 12] . High plasma concentrations of triglycerides, cholesterol, free fatty acids, insulin and leptin found in the metabolic syndrom model of obese Zucker rats were reduced in animals that received resveratrol [13] . In the light of the beneficial effects of the drug on the metabolic state and complications associated with diabetes it seems conflicting that prolonged exposure to resveratrol for 24 hours induces apoptosis in isolated beta-cells and beta-cell lines (HIT-T15 and RINm5F), as recently shown [14] . In isolated pancreatic islets resveratrol has been shown to reversibly and dosedependently inhibit insulin secretion in a protein kinase C dependent manner consistent with a repression of the amplifying pathway of insulin release [15] [16] [17] . In a recent study we have shown a reversible suppression of glucose-, hypotonicity-and tolbutamide-induced membrane depolarization and electrical activity by resveratrol in INS-1E rat insulinoma cells and a complete inhibition of glucose-induced insulin release within 1 hour, suggesting a block of the triggering pathway of insulin secretion [18] .
Insulin and insulin-like growth factor 1 (IGF-1) act as growth factors in beta-cells [19, 20] . Decreased betacell mass of insulin-receptor knock-out mice and insulin receptor substrate 2-deficient mice are consistent with an auto/paracrine action of insulin and antiapoptotic effects in beta-cells [21] as are data from MIN6 insulin secreting cells showing that high glucose stimulates proliferation and protects cells against apoptosis, which can be prevented by an anti-insulin antibody or PI3K inhibition [22] .
Since resveratrol interferes with signaling pathways that regulate beta-cell proliferation/apoptosis and inhibits insulin release from native beta-cells and insulinoma cells, we performed the present study to determine long term effects of resveratrol (0-72 hours) on proliferation, cell cycle distribution and apoptosis and Akt and AMP kinase signaling in INS-1E rat insulinoma cells.
Materials and Methods

Chemicals and reagents
All salts and chemicals used for the preparation of experimental solutions and cell culture media were p.a. grade. Resveratrol (3,4',5-trihydroxy-trans-stilbene), accutase solution, 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo [1,5-a] pyrimidine (compound C), AICA riboside, crystal violet solution and porcine insulin were obtained from SigmaAldrich. Stock solutions of resveratrol (10 mM and 100 mM) were prepared in ethanol and stored in aliquots at 4°C. The mouse monoclonal anti-phosphatidylserine antibody clone 1H6 (anti-PS) and fluoroisothiocyanate (FITC)-labelled goat antimouse IgG 1 were from Upstate Cell Signaling Solutions and SouthernBiotech, respectively. 7-amino-actinomycin D (7-AAD) was obtained from Beckman Coulter. Nuclear isolation medium-4,6-diamidino-2-phenylindole dihydrochloride (NIM-DAPI) and DNA reference calibrator were from NPE systems. The CaspACE™ FITC-VAD-FMK in situ marker was obtained from Promega. Rabbit monoclonal Akt (pan) (C67E7) and phosphoAkt (Ser473) (D9E) primary antibodies and the HRP-linked antirabbit IgG secondary antibody were from Cell Signaling Technology.
Cell culture
INS-1E cells [23] were cultured in RPMI-1640 medium containing 2.1 mM L-glutamine, 11 mM D-glucose, 23.8 mM NaHCO 3 supplemented with 50 µM β-mercaptoethanol, 1 mM sodium pyruvate, 10 mM HEPES, 10% fetal calf serum (FCS), 100 µg/ml penicillin and 100 µg/ml streptomycin in a humidified atmosphere at 37 °C, 5% CO 2 and 95% air. Except for the experiments shown in Fig. 1B , cells were kept under 11 mM glucose throughout all incubations. Cells were subcultured every third day by trypsin/EDTA treatment. For the measurement of cell proliferation and apoptosis cells were subcultured in 2 ml of RPMI medium into 9.2 cm² tissue culture dishes at a cell density of 2x10 6 cells/ml. For flow cytometrical measurements cells were detached with accutase or trypsin/EDTA.
Measurement of cell proliferation
INS-1E cells were seeded one day before resveratrol treatment into 9.2 cm² tissue culture dishes each containing 2 ml of RPMI medium. Resveratrol was added to the cells at concentrations of 10, 50 and 100 µM, respectively. Untreated cells or cells treated with the solvent (1‰ ethanol) served as control. Nine regions were marked on the bottom of each dish. Cells were allowed to adhere and proliferate for ~1 day. Thereafter solvent or resveratrol was added at the respective concentrations and cells were counted immediately (time point 0) as well as 24, 48 and 72 hours after addition, respectively, using a Motic AE 20 microscope. Each cell counting was repeated two times by two independent observers (C.B. and T.K.) in a blinded manner. The mean of the two counts in each region was taken as cell count per region and the change in cell number over time was related to the value within an individual region. All experiments were repeated at least 7 times.
Crystal violet cell adhesion assay
The number of adherent cells was determined colorimetrically by a crystal violet test modified from [24] . For the standard curve cells were seeded at a density of 5000, 10000, 20000, 37500, 50000 and 75000 cells/ml per well, respectively, on a 96-well plate. Wells without cells containing crystal violet solution served as blanks. For experiments cells were seeded at a density of 20000 cells/ml. Cells were allowed to adhere for 4 hours and then further incubated for 48 hours in the presence of drugs as indicated. Cells were kept under standard culture conditions in RPMI-1640 medium (11 mM glucose) supplemented with serum throughout the experiment. Crystal violet in the destaining solution was measured photometrically at 570 nm using a Zenyth 3100 multimode reader (Anthos Beckman Coulter). Data are given as cells/ml after 48 hours of incubation.
Flow cytometry
Induction of apoptosis, cell cycle distribution and caspase activity was measured with a Cell Lab Quanta TM SC flow cytometer (Beckman Coulter) equipped with a 488 nm laser, a mercury arc lamp and the appropriate filter sets for excitation and emission as specified below. Calibration for cell diameter/ volume measurements was performed by using Flow check beads (Beckman Coulter) with a nominal diameter of 10 µm. Side scatter (SS) was taken as measure for the cell granularity. For assessment of apoptosis, cell cycle and caspase activation the analysed signals were gated for cells ≥ 7 µm and ≤ 14 µm. Experiments were repeated 4 times.
Assessment of apoptosis: Cells were subcultured 2 days before treatment with 10, 50 or 100 µM resveratrol or ethanol (1‰; solvent controls). Immediately after starting the treatment (time point 0) as well as 24, 48 and 72 hours later cells were harvested and centrifuged at 300xg for 5 minutes. The supernatant was discarded and the cell pellets were resuspended in a buffer containing (in mM): 150 NaCl, 5 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 HEPES, pH 7.4, 1% bovine serum albumin. in a final volume of 400 µl. The samples were analysed within one hour using 488 nm laser excitation. PS negative/7-AAD negative cells were considered as non apoptotic, PS positive/ 7-AAD negative cells as early apoptotic, PS positive/7-AAD positive cells as late apoptotic. Quadrant regions were set according to the distribution of control cells.
Assessment of cell cycle arrest: After treatment with resveratrol in different concentrations (10, 50 and 100 µM) for 0, 24, 48, 72 hours the cells were washed with PBS, harvested and stained with NIM-DAPI for 10 minutes at room temperature. Thereafter cells were washed once with PBS and analysed. The excitation light from the mercury arc lamp was passed through a 355/37 nm bandpass filter. The emission light was directed towards the photomultiplier tube by a dichroic mirror (cut-off 550 nm) and passed through a 465/30 nm bandpass filter. The instrument was calibrated using trout red blood cells (DNA reference calibrator, NPI systems).
Measurement of caspase activation: Caspase activation was measured using CaspACE™ FITC-VAD-FMK in situ marker, a fluoroisothiocyanate (FITC)-conjugate of the membrane permeable pan-caspase inhibitor VAD-FMK (Promega). The excitation wavelength was 288 nm, emission was measured at 525 nm. Cells treated for 24 or 48 hours with 10, 50 or 100 µM resveratrol or ethanol (1‰; solvent controls) were washed once with PBS, detached from the culture dish with trypsin/ EDTA and centrifuged for 5 minutes at 300xg, washed twice with PBS, incubated with caspase inhibitor reagent for 30 minutes at 37 °C, washed twice and resuspended to 1-2x10 6 cells/ ml for measuring caspase activation by flow cytometry. 
SDS-PAGE and Immunoblotting
Cells were grown in 100 mm petri dishes for 3 days tõ 70% confluency and treated with resveratrol in the absence or presence of insulin for 1 hour at the indicated concentrations. Equal volumes of cell lysates were subjected to SDS-PAGE (4-15% Tris-HCl) and proteins were blotted onto nitrocellulose membranes (PROTRAN BA 85, Schleicher & Schuell). Membranes were incubated over night with primary antibodies at dilutions of 1:1000 and for 2 hours with the secondary antibody (1:2000) . Protein bands were visualized with SuperSignal West Pico Chemiluminescent Substrate (Pierce). Images were acquired using a BioSpectrum AC Imaging System and VisionWorks LS Software (UVP).
Statistics and data presentation
Data are expressed as mean±SEM. Statistical comparisons were performed using paired or unpaired student's t-test, where applicable. P<0.05 between groups was considered as statistically significant (* or §, ** and *** denotes p<0.05, p<0.01 and p<0.001, respectively; ns, not significant). For all series of experiments control measurements using solvent (1‰ ethanol) were performed. Since in none of the experimental series a significant difference between untreated and ethanol treated samples was found the data obtained from untreated cells were omitted from most graphs for simplicity or only data of untreated cells are shown. Data were analysed and plotted using GraphPad Prism version 5.00 (GraphPad Software, San Diego California, USA) or Igor Pro 6.03 (WaveMetrics, Lake Oswego, USA) for Macintosh. 
Results
Effect of resveratrol and glucose concentration on the proliferation of INS-1E rat insulinoma cells
Since resveratrol is known to exert proapoptotic and antiproliferative effects in various cell types, we investigated the influence of the drug (10-100 µM) on the proliferation of INS-1E cells over 72 hours. Fig. 1A shows that under control conditions (11 mM medium glucose) the cell number increased to 187.36±12.94% (n=96), 302.99±25.58% (n=96) and 463.19±36.81% (n=96) within 24, 48 and 72 hours, respectively. Addition of solvent (ethanol 1‰) or 10 µM resveratrol did not significantly change the growth rate. In the presence of 50 and 100 µM resveratrol, however, cell growth was dose-and timedependently inhibited; significant inhibition was evident already after 24 hours at 100 µM (112.76±8.55%, n=55) and after 72 hours at 50 µM resveratrol (311.50±57.74%, n=64). The dependence of INS-1E cell proliferation on the medium glucose concentration is shown in Fig. 1B . Whereas proliferation was unaffected by reduction from 11 to 9 or 7 mM, proliferation was significantly attenuated under 5 mM glucose.
Effect of resveratrol on cell cycle distribution
To assess a possible effect of resveratrol on the cell cycle distribution, exponentially growing cells treated with resveratrol (10, 50 and 100 µM) or ethanol were analysed by DAPI staining and flow cytometry immediately after starting incubation as well as 24, 48 and 72 hours thereafter (Fig. 2) . Under 100 µM resveratrol the arrest occurred in the G0/G1 phase with a concomitant reduction of cells in the S-and G2 phase between 24 and 72 hours. Treatment with 50 µM resveratrol for 24 hours, however, led to an accumulation in the S phase paralleled by a slight, though not significant, reduction of cells in the G0/G1-and G2 phase. Prolonged treatment with 50 µM resveratrol for 48-72 hours led to an accumulation of cells arrested in the G0/G1 phase and a reduction of cells in the S-and G2 phase. l0 µM resveratrol did not have any significant effect on the cell cycle distribution.
Resveratrol induces apoptosis in INS-1E cells
To test if the observed cell cycle arrest was paralleled by an induction of apoptosis, we analysed INS-1E cells treated with resveratrol (10, 50 and 100 µM) for breakdown of phosphatidylserine (PS) asymmetry, loss of cell membrane integrity and altered cell morphology including cell shrinkage, which are prominent signs of programmed cell death [25] [26] [27] . The appearance of PS residues at the outer leaflet of the cell membrane is an early sign of apoptosis. In addition of PS exposure, late apoptotic cells are characterised by a loss of cell membrane integrity and can be discriminated from early apoptotic cells by simultaneous staining with the DNAspecific viability dye 7-AAD. Fig. 3A shows the distribution of non apoptotic (PS-/7-AAD-; upper panel), early apoptotic (PS+/7-AAD-; middle panel) and late apoptotic cells (PS+/7-AAD+; lower panel) between 0 and 72 hours in the absence and presence of resveratrol. Among untreated cells and cells exposed to 10 µM resveratrol the different cell populations remained unchanged over the whole time course, whereas the percentage of non apoptotic cells progressively decreased over time in the presence of 50 or 100 µM resveratrol. Simultaneously a significant increase of early apoptotic cells occurred. The percentage of late apoptotic cells (PS+/7-AAD+) was only transiently increased after 24 and 48 hours with no significant changes after 72 hours as compared to untreated cells due to the rapid fragmentation of cells under 50 and 100 µM resveratrol which then appear as debris (diameter <7 µm). Fig. 3B shows the distribution of non 
Morphology of apoptotic cells
Induction of apoptosis in INS-1E cells exposed to 50 or 100 µM resveratrol was paralleled by a time-and concentration-dependent reduction of the diameter of early apoptotic (PS+/7-AAD-) cells indicating apoptotic volume decrease (AVD) induced by resveratrol (Fig. 4A) . A smaller, though significant, diameter reduction over time was also evident in untreated and solvent-treated cells. Since we observed a similar shrinkage also in untreated, non apoptotic (PS-/7-AAD-) cells (not shown), we assume that this effect is most likely due to the culture conditions. Cell shrinkage under resveratrol was accompanied by a progressive increase of the side scatter (SS) signal (Fig. 4B) , which indicates an increase of cell granularity due to membrane blebbing during apoptosis.
Caspase activation by resveratrol
Certain manifestations of apoptosis are associated with caspase activation [28, 29] . Therefore we examined if in INS-1E cells the proapoptotic effect of resveratrol was associated with an increase of caspase activity, which was measured by flow cytometry using a cell permeable fluorescent caspase inhibitor. Resveratrol (100 µM) led to a significant increase of caspase positive cells already after 24 hours followed by a further increase after 48 hours (Fig. 5A) . Under 50 µM caspase activity was significantly augmented after 48 hours, whereas 10 µM had no effect. Fig. 5B shows representative histograms obtained after 48 hours from control cells and resveratrol treated cells.
Effect of resveratrol and insulin on Akt phosphorylation
The 3'-phosphoinositide-dependent serine/threonine protein kinase Akt is a prominent mediator of the actions of insulin and insulin-like growth factor 1 (IGF-1) in the maintenance of the beta-cell mass by stimulating proliferation and inhibiting apoptosis [19] . Since resveratrol has been described as a potent inhibitor of phosphoinositide 3-kinase (PI3K) in muscle cells [9] , we tested by immunoblotting the effect of resveratrol on the phosphorylation of Akt, a downstream target of PI3K. As shown in Fig. 6 , resveratrol (50 and 100 µM) dose-dependently inhibited Akt phosphorylation within 1 hour. At 100 µM the phosphorylated protein was reduced by ~70%. In the presence of 10 µM insulin in the cell culture medium, basal Akt phosphorylation under control conditions (11 mM medium glucose, presence of serum) was ~4-fold increased and the inhibitory effects of increasing resveratrol concentrations were significantly attenuated.
Effect of AMPK inhibition or insulin on caspase activity and INS-1E cell proliferation
To investigate a possible role of AMP-activated protein kinase (AMPK) in resveratrol-mediated apoptosis, we tested the effect of resveratrol on caspase activation and cell proliferation in the absence and presence of the AMPK inhibitor compound C. We chose a concentration of 50 µM resveratrol and tested its effect after 48 hours (Fig. 5) . Similar to 50 µM resveratrol, compound C (10 µM) alone caused a significant increase of caspase positive cells by ~20% and an attenuation of cell proliferation compared to control cells (Fig. 7A and B, respectively) . Importantly, simultaneous treatment with compound C and resveratrol did not produce a significant additive effect on caspase activation if compared to the effects of the two substances alone (Fig. 7A) . Addition of 10 µM insulin to the culture medium did neither counteract resveratrol-induced caspase activation nor its antiproliferative effect.
Discussion
We show that long-term exposure of clonal INS-1E rat insulinoma cells to resveratrol ≥ 50 µM leads to a concentration-and time-dependent inhibition of cell proliferation and S or G0/G1 phase cell cycle arrest and induction of apoptosis. This is evident from apoptotic volume decrease (AVD), breakdown of phosphatidylserine (PS) asymmetry, increased cell granularity and caspase activation as are prominent signs of programmed cell death [25, 26, [28] [29] [30] .
Our results compare to data from other tumour cell lines including hepatoma, glioma, lymphoma cells as well as prostate, breast, promyelocytic HL-60 and colon cancer cells, where resveratrol (tested in wide range of concentrations from 10-300 µM) has been shown to exert anticancerogenic, antimitogenic and proapoptotic effects through multiple, though cell type specific signaling pathways [31] [32] [33] [34] [35] [36] [37] . More generally the resveratrol effects seem to be related to altered expression patterns of cyclins and cyclin-dependent kinases [34, 35, 38] . Other mechanisms involve TRAIL-induced apoptosis associated with survivin depletion [39] , induction of p53 and increased Bax levels [35] , inhibition of BCL-6 expression with in-creased expression of p27, p53 and CD69 [40] , caspase-3 activation and induction of cytochrome c release from mitochondria with activation of caspase-9 [35, 37, 41] . Recently resveratrol (100 µM applied over 24 hours) has been found to induce apoptosis in HIT-T15 and RINm5F insulinoma cells as well as in native beta-cells by binding to the sulfonylurea receptor SUR1 [14] .
To unravel the mechanism underlying resveratrolinduced growth inhibition and apoptosis in INS-1E cells, we studied the effects of the compound on AMP-activated protein kinase (AMPK) and Akt (PKB) signaling pathways, which are involved in beta-cell proliferation and maintenance of beta-cell mass under normal conditions as well as in case of beta-cell dysfunction in type 2 diabetes [19, 20, 42] . Resveratrol is a potent activator of AMPK in neurons, liver tissue and cardiac myocytes [5, 8, 13, 43] . In chemoresistant HT-29 cancer cells and MIN6N8 insulinoma cells AMPK activation by resveratrol exerts proapoptotic effect due to increased ROS production [6, 7] . A similar effect of resveratrol is unlikely in our experimental system since we find that activation of AMPK by AICA riboside does not stimulate apoptosis under control conditions, nor does it significantly add to the resveratrol effect if applied simultaneously (data not shown). However, inhibition of AMPK with compound C strongly promotes caspase activation and inhibits proliferation (Fig. 7) , which implies that intact AMPK signaling is essential for INS-1E cell viability. If resveratrol inhibited AMPK, an additive effect of compound C and resveratrol could be expected. A stimulation of AMPK by resveratrol might conversely diminish caspase activation which would rather imply an antiapoptotic effect of the phytostilbene. Therefore AMPK is probably not a major target of resveratrol involved in stimulating apoptosis in INS-1E cells.
Immunoblotting revealed that resveratrol significantly reduces the amount of phosphorylated Akt protein in a concentration-dependent manner after 1 hour of incubation (Fig. 6 ) which depicts the insulin/IGF-1 signaling pathway as a major target of resveratrol in INS-1E cells. Similarly, in INS-1 cells the glucocorticoid dexamethasone has been shown to induce cell death by interfering with IGF-1 signaling [20] .We further show that excess insulin in the culture medium can at least partly overrule the blocking effect of resveratrol on Akt phosphorylation, though the compensatory property of insulin is obviously not sufficient to prevent the antiproliferative and proapoptotic effect (Fig. 7) , which points at additional sites of action besides insulin receptor signaling. The massive increase of Akt phosphorylation in the presence of excess insulin clearly indicates the significance of auto/ paracrine signaling in beta-cells as previously demonstrated [44] . Addition of insulin to the culture medium or stimulation of insulin release by high concentrations of extracellular K + used to depolarize betacells has been shown to suppress beta-cell apoptosis induced by glucose deprivation [45] .
Glucose is a crucial factor for the survival of betacells [46] . Consistently we find that the proliferation rate of INS-1E cells is significantly reduced by lowering the medium glucose concentration (Fig. 1B) . Under the given standard culture conditions for INS-1E cells [23] , which are commonly used also for other beta-cell lines as well as primary beta-cells [14, 20] (i.e., RPMI 1640 medium containing 11 mM glucose, supplemented with 5-10% FCS), the cells are obviously metabolically adapted to hyperglycemic conditions and the setpoint for growth arrest appears to be shifted to higher glucose concentrations. Since we observed growth arrest also in serum free medium even under 11 mM glucose (data not shown), we used standard culture conditions throughout all incubations to avoid an overestimation of the resveratrol effect due to omission of glucose and/or serum. In MIN6 clonal beta-cells glucose was shown to stimulate proliferation and to protect cells against apoptosis [22] . This effect was prevented by an anti-insulin antibody, PI3K inhibition or by the L-type Ca 2+ channel blocker nifedipine. Importantly, we previously demonstrated that in INS-1E cells resveratrol inhibits stimulus-secretioncoupling by blocking L-and T-type Ca 2+ channels and glucose/swelling-dependent Cl -channels [18] so that it is feasible that the proapoptotic effect of resveratrol is the result of an indirect inhibition of insulin receptor signaling by a suppression of insulin release and a direct inhibition of promitotic/antiapoptotic Akt signaling. Insulin receptor expression in INS-1E cells was confirmed by reverse transcriptase and real-time PCR and remained unaltered within 48 hours in resveratrol treated cells (data not shown). However, at that point we cannot rule out decreased insulin receptor expression and/or degradation at later points along the timeline, which might accelerate apoptosis.
Cell shrinkage during programmed cell death, referred to as apoptotic volume decrease (AVD), is accomplished by the activation of Cl -and K + channels and inhibition of these ion extrusion pathways can prevent apoptosis [27, 47, 48] . In our previous work we found that resveratrol, besides blocking glucose/ swelling-dependent Cl -channels, also inhibits K ATP channels [18] . The fact that this inhibition does obviously not prevent AVD implies further ion extrusion pathways to be involved in AVD in INS-1E cells. Although resveratrol has the property to reduce insulin release in vitro [15] [16] [17] as well as in vivo [11] , and long term exposure induces apoptosis in other beta-cell lines (HIT-T15 and RIN-m5F) and primary beta-cells [14] , no in vivo data regarding antiproliferative and proapoptotic effects of the drug in the pancreas are so far available. Therefore in vivo studies will be necessary to validate the significance of our findings and the data of others demonstrating direct effects of resveratrol in beta-cell lines and primary beta-cells. To that point it seems that the beneficial effects of the drug found in animal models (hypoglycemic and hypolipidemic effects due to increased insulin responsiveness of hepatocytes, adipocytes and skeletal muscle, stimulated hepatic glycogen synthesis, delayed the onset of insulin resistance, diminished renal dysfunction) [10, 11] outweigh possible adverse effects. This is probably due to the fact that the concentrations of resveratrol tested in most in vitro studies (10-100 µM) are unlikely to be achieved in vivo upon oral or intravenous administration due to the rapid metabolism of the compound, so that plasma concentrations of untransformed resveratrol are fairly low (peak concentrations of ~2.4 nM unconjugated and ~180 nM total resveratrol assuming a daily consumption of ~375 ml red wine, the richest source of resveratrol) [4] . However, enterohepatic recirculation, binding to plasma proteins and an up to ~30-fold accumulation of unconjugated resveratrol over plasma concentrations in certain organs like the liver and kidneys may delay the elimination of the drug from the body and bring about prolonged beneficial effects [4, 49, 50] , which make the compound a promising therapeutic tool. Yet, given the multiple cellular target sites of resveratrol which can mediate beneficial or adverse effects, synthetic resveratrol analogues which are effective at lower concentrations than the naturally occurring drug will have to be carefully tested for potential harmful side effects.
We conclude that the antiproliferative/proapoptotic effect of resveratrol in the beta-cell line INS-1E is due to direct negative interference with antiapoptotic Akt signaling, which might be aggravated by a disruption of auto/paracrine insulin signaling as a possible consequence of inhibited insulin release.
